Fig. 8From: The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276Summary of the genetic and pharmacological events that distinguish regulation and function of CD276 or PD-L1 by the MDM2/p53 axis. The left and right panels summarize data highlighting the elevation of PD-L1 or CD276, respectively, after treatment with Nutlin-3Back to article page